Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Phathom Pharmaceuticals, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-19Dec-31-18
Revenues0.00.0
Cost of goods sold0.00.0
Gross profit0.00.0
Research and development20.40.0
General and administrative6.91.2
EBIT-27.3-1.2
Pre-tax income-255.1-1.3
Income taxes0.00.0
            Tax rate0.0%0.0%
Net income-255.1-1.3
 
Diluted EPS($22.45)($0.21)
Shares outstanding (diluted)11.46.1
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy